DelMar Pharmaceuticals to Host Key Opinion Leader Summit on Glioblastoma Multiforme and the Potential for Treatment with VAL-083 Nov 5, 2019 08:30AM
Maxim Group Starts Del Mar Pharma (DMPI) at Buy Sep 6, 2019 07:42AM
Delmar Pharma (DMPI) Prices 6.75M Share Common Offering at $1/Sh Aug 14, 2019 09:11AM
DelMar Pharmaceuticals Announces Pricing Of $6.8 Million Underwritten Public Offering Aug 14, 2019 09:10AM
DelMar Pharmaceuticals Announces Extension Of Rights Offering To July 12, 2019 Jun 25, 2019 05:28PM


Jun 11, 2019 05:30AM Delmar Pharmaceuticals Updates The Terms Of Previously Announced Rights Offering
Jun 5, 2019 03:10PM DelMar Pharmaceuticals Announces Closing of Financing
Jun 3, 2019 08:32AM Delmar Pharma (DMPI) Announces 1.17M Share Registered Direct Offering at $3.10/Sh
Jun 3, 2019 08:30AM DelMar Pharmaceuticals Announces $3.6 Million Registered Direct Offering
May 29, 2019 09:00AM DelMar Pharmaceuticals Updates Key Dates of Rights Offering
May 8, 2019 08:12AM DelMar Pharmaceuticals Announces Key Dates and Timeline for Stockholder Participation in Rights Offering
Aug 14, 2017 01:33PM Maxim Group Downgrades Del Mar Pharma (DMPI) to Hold
Apr 3, 2014 09:24AM Del Mar Pharma (DMPI) Started at Buy at Maxim Group